theophylline extended-release / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
theophylline extended-release / Generic mfg.
NCT04240821: Theophylline for Treatment of Pseudohypoparathyroidism

Enrolling by invitation
2
34
US
Theophylline ER, Theophylline elixir
Ashley Shoemaker
Pseudohypoparathyroidism, Pseudohypoparathyroidism Type 1a, Albright Hereditary Osteodystrophy
06/26
06/26
NCT04551170: Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old

Recruiting
2
34
US
Theophylline, Theo-24, Elixophyllin, Placebo
Vanderbilt University Medical Center
Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy, Pseudohypoparathyroidism Type 1a
06/26
06/26
NCT03029429: Theophylline Treatment for Pseudohypoparathyroidism

Recruiting
2
34
US
Theophylline, Theo-24, Elixophyllin, Placebos, placebo
Vanderbilt University Medical Center, Harvard University
Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy
07/26
11/26

Download Options